151 related articles for article (PubMed ID: 36067066)
1. Optimization and Characterization of Low-Molecular-Weight Chitosan-Coated Baicalin mPEG-PLGA Nanoparticles for the Treatment of Cataract.
Li N; Zhao Z; Ma H; Liu Y; Nwafor EO; Zhu S; Jia L; Pang X; Han Z; Tian B; Pan H; Liu Z; Pan W
Mol Pharm; 2022 Nov; 19(11):3831-3845. PubMed ID: 36067066
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
[TBL] [Abstract][Full Text] [Related]
3. [Transport of mPEG-PLGA nanoparticles across the rat nasal mucosa].
Wang JT; Lin DH; Qin LF; Wen Z; Guo GP
Yao Xue Xue Bao; 2013 May; 48(5):752-8. PubMed ID: 23888701
[TBL] [Abstract][Full Text] [Related]
4. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells].
Wen Z; Li G; Lin DH; Wang JT; Qin LF; Guo GP
Yao Xue Xue Bao; 2013 Dec; 48(12):1829-35. PubMed ID: 24689242
[TBL] [Abstract][Full Text] [Related]
5. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation.
Pandit J; Sultana Y; Aqil M
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1397-1407. PubMed ID: 27855494
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
7. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol.
Guan Q; Sun S; Li X; Lv S; Xu T; Sun J; Feng W; Zhang L; Li Y
J Mater Sci Mater Med; 2016 Feb; 27(2):24. PubMed ID: 26704541
[TBL] [Abstract][Full Text] [Related]
8. PLGA Nanoparticle Platform for Trans-Ocular Barrier to Enhance Drug Delivery: A Comparative Study Based on the Application of Oligosaccharides in the Outer Membrane of Carriers.
Jiang G; Jia H; Qiu J; Mo Z; Wen Y; Zhang Y; Wen Y; Xie Q; Ban J; Lu Z; Chen Y; Wu H; Ni Q; Chen F; Lu J; Wang Z; Li H; Chen J
Int J Nanomedicine; 2020; 15():9373-9387. PubMed ID: 33262593
[TBL] [Abstract][Full Text] [Related]
9. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization and uptake of PEG-coated, muco-inert nanoparticles in HGC-27 cells, a mucin-producing, gastric-cancer cell line.
Lin D; Li G; Qin L; Wen Z; Wang J; Sun X
J Biomed Nanotechnol; 2013 Dec; 9(12):2017-23. PubMed ID: 24266257
[TBL] [Abstract][Full Text] [Related]
11. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
[TBL] [Abstract][Full Text] [Related]
12. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
14. Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticles.
Ait Bachir Z; Huang Y; He M; Huang L; Hou X; Chen R; Gao F
Int J Nanomedicine; 2018; 13():5657-5671. PubMed ID: 30288039
[TBL] [Abstract][Full Text] [Related]
15. Chitosan coated PLGA nanoparticles amplify the ocular hypotensive effect of forskolin: Statistical design, characterization and in vivo studies.
Khan N; Ameeduzzafar ; Khanna K; Bhatnagar A; Ahmad FJ; Ali A
Int J Biol Macromol; 2018 Sep; 116():648-663. PubMed ID: 29723623
[TBL] [Abstract][Full Text] [Related]
16. Optimization and Characterization of Brimonidine Tartrate Nanoparticles-loaded In Situ Gel for the Treatment of Glaucoma.
Sharma PK; Chauhan MK
Curr Eye Res; 2021 Nov; 46(11):1703-1716. PubMed ID: 33844617
[No Abstract] [Full Text] [Related]
17. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin.
Abd El Hady WE; Mohamed EA; Soliman OAE; El-Sabbagh HM
Int J Nanomedicine; 2019; 14():7191-7213. PubMed ID: 31564873
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing.
Du J; Sun Y; Shi QS; Liu PF; Zhu MJ; Wang CH; Du LF; Duan YR
Int J Mol Sci; 2012; 13(1):516-533. PubMed ID: 22312268
[TBL] [Abstract][Full Text] [Related]
19. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
[TBL] [Abstract][Full Text] [Related]
20. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
